Search Results for: CLINICAL TRIALS Its Time to
Articles
December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal December 11, 2011
Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide collaboration to jointly develop and commercialize Reata's...
December 4, 2011
12/6/2011 December 4, 2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users Nanion's ion channel screening platform, the SyncroPatch 96, has been...
November 27, 2011
11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...
November 10, 2011
11/15/2011 November 10, 2011
Lundbeck & Otsuka Enter Long-Term CNS Agreement, Deal Has $1.8-Billion Potential Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S recently...
November 10, 2011
Accentia Biopharmaceuticals to Sell Analytica for $10 Million November 10, 2011
Accentia Biopharmaceuticals, Inc. recently announced it has entered into a series of agreements to strengthen its financial position, improve its...
October 27, 2011
11/01/2011 October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...
October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner October 27, 2011
Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing a cancer immunotherapy concept that is currently in Phase...
October 20, 2011
10/25/2011 October 20, 2011
Abbott to Separate Into Two Leading Companies Abbott recently announced it plans to separate into two publicly traded companies, one...
October 20, 2011
Halozyme Announces Positive Results From Roche's Phase III Trial October 20, 2011
Halozyme Therapeutics, Inc. recently announced that the Phase III HannaH trial, conducted by Roche, showed that women with HER2-positive early...
October 13, 2011
10/17/2011 October 13, 2011
Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...
October 9, 2011
10/11/2011 October 9, 2011
Carticept Medical Receives 510(k) Clearance for Navigator Delivery System Carticept Medical, Inc., a developer of innovative products for the treatment...
October 9, 2011
Intellect Neurosciences & ViroPharma Announce $126.5-Million Global Licensing Agreement October 9, 2011
Intellect Neurosciences, Inc. recently announced that it has granted an exclusive license to ViroPharma Incorporated regarding certain of Intellect's licensed...
September 27, 2011
10/4/2011 September 27, 2011
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H Talon Therapeutics, Inc. recently announced its NDA seeking...
September 27, 2011
CoreRx Adds Additional Capabilities With New Tablet Press September 27, 2011
CoreRx, a leader in early drug contract development, has expanded manufacturing capabilities to include the OYSTAR Manesty FLEXITAB, a fully...
September 25, 2011
9/27/2011 September 25, 2011
Thermo Fisher Scientific Introduces New Imaging ATR Accessory Thermo Fisher Scientific Inc., a world leader in serving science, recently announced...
September 18, 2011
9/20/2011 September 18, 2011
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices Unilife Corporation recently announced the development of its AutoInfusor portfolio...
September 18, 2011
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices September 18, 2011
Unilife Corporation recently announced the development of its AutoInfusor portfolio of subcutaneous infusion systems for the patient self-administration of drugs...
September 1, 2011
9/6/2011 September 1, 2011
Jennerex's Virus-Based Drug Targets & Infects Tumors Jennerex, Inc. recently announced the publication of clinical data on its lead product...
September 1, 2011
Cyclacel Announces Phase II Trial of Sapacitabine September 1, 2011
Cyclacel Pharmaceuticals, Inc. recently announced that the first patient has been dosed in an investigator-initiated, translational, Phase II clinical study...
September 1, 2011
Jennerex's Virus-Based Drug Targets & Infects Tumors September 1, 2011
Jennerex, Inc. recently announced the publication of clinical data on its lead product JX-594. For the first time in humans,...
